chr16-1219029-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_021098.3(CACNA1H):​c.5947T>C​(p.Leu1983Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.608 in 1,549,694 control chromosomes in the GnomAD database, including 290,331 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.64 ( 31617 hom., cov: 32)
Exomes 𝑓: 0.60 ( 258714 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.70

Publications

23 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 16-1219029-T-C is Benign according to our data. Variant chr16-1219029-T-C is described in ClinVar as Benign. ClinVar VariationId is 518260.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.7 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.855 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5947T>C p.Leu1983Leu synonymous_variant Exon 34 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5947T>C p.Leu1983Leu synonymous_variant Exon 34 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5962T>C p.Leu1988Leu synonymous_variant Exon 33 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5932T>C p.Leu1978Leu synonymous_variant Exon 33 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5929T>C p.Leu1977Leu synonymous_variant Exon 33 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5929T>C p.Leu1977Leu synonymous_variant Exon 34 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5914T>C p.Leu1972Leu synonymous_variant Exon 34 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5908T>C p.Leu1970Leu synonymous_variant Exon 34 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5896T>C p.Leu1966Leu synonymous_variant Exon 33 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5890T>C p.Leu1964Leu synonymous_variant Exon 33 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5947T>C p.Leu1983Leu synonymous_variant Exon 34 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5896T>C p.Leu1966Leu synonymous_variant Exon 33 of 35 ENSP00000518774.1
CACNA1HENST00000711483.1 linkc.5947T>C p.Leu1983Leu synonymous_variant Exon 34 of 35 ENSP00000518772.1
CACNA1HENST00000621827.2 linkn.5947T>C non_coding_transcript_exon_variant Exon 34 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1866T>C non_coding_transcript_exon_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*995T>C non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3765T>C non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5391T>C non_coding_transcript_exon_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*888T>C non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*806T>C non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1526T>C non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*614T>C non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*581T>C non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5896T>C non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5947T>C non_coding_transcript_exon_variant Exon 34 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5914T>C non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*1063T>C non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1866T>C 3_prime_UTR_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*995T>C 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3765T>C 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5391T>C 3_prime_UTR_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*888T>C 3_prime_UTR_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*806T>C 3_prime_UTR_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1526T>C 3_prime_UTR_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*614T>C 3_prime_UTR_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*581T>C 3_prime_UTR_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*1063T>C 3_prime_UTR_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000711455.1 linkc.5888-19T>C intron_variant Intron 33 of 35 ENSP00000518768.1
CACNA1HENST00000711456.1 linkc.5887+378T>C intron_variant Intron 33 of 33 ENSP00000518769.1

Frequencies

GnomAD3 genomes
AF:
0.640
AC:
97285
AN:
151948
Hom.:
31593
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.662
Gnomad AMI
AF:
0.572
Gnomad AMR
AF:
0.699
Gnomad ASJ
AF:
0.712
Gnomad EAS
AF:
0.877
Gnomad SAS
AF:
0.565
Gnomad FIN
AF:
0.710
Gnomad MID
AF:
0.709
Gnomad NFE
AF:
0.587
Gnomad OTH
AF:
0.648
GnomAD2 exomes
AF:
0.651
AC:
100039
AN:
153568
AF XY:
0.640
show subpopulations
Gnomad AFR exome
AF:
0.664
Gnomad AMR exome
AF:
0.736
Gnomad ASJ exome
AF:
0.691
Gnomad EAS exome
AF:
0.889
Gnomad FIN exome
AF:
0.693
Gnomad NFE exome
AF:
0.591
Gnomad OTH exome
AF:
0.642
GnomAD4 exome
AF:
0.605
AC:
845136
AN:
1397628
Hom.:
258714
Cov.:
48
AF XY:
0.603
AC XY:
415485
AN XY:
689396
show subpopulations
African (AFR)
AF:
0.669
AC:
21133
AN:
31590
American (AMR)
AF:
0.728
AC:
25975
AN:
35682
Ashkenazi Jewish (ASJ)
AF:
0.695
AC:
17477
AN:
25156
East Asian (EAS)
AF:
0.901
AC:
32203
AN:
35732
South Asian (SAS)
AF:
0.562
AC:
44534
AN:
79220
European-Finnish (FIN)
AF:
0.690
AC:
33087
AN:
47960
Middle Eastern (MID)
AF:
0.701
AC:
3987
AN:
5684
European-Non Finnish (NFE)
AF:
0.585
AC:
630478
AN:
1078642
Other (OTH)
AF:
0.626
AC:
36262
AN:
57962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
17161
34321
51482
68642
85803
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17676
35352
53028
70704
88380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.640
AC:
97352
AN:
152066
Hom.:
31617
Cov.:
32
AF XY:
0.648
AC XY:
48152
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.661
AC:
27437
AN:
41490
American (AMR)
AF:
0.700
AC:
10701
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.712
AC:
2473
AN:
3472
East Asian (EAS)
AF:
0.877
AC:
4517
AN:
5152
South Asian (SAS)
AF:
0.564
AC:
2721
AN:
4822
European-Finnish (FIN)
AF:
0.710
AC:
7525
AN:
10594
Middle Eastern (MID)
AF:
0.701
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
0.587
AC:
39875
AN:
67930
Other (OTH)
AF:
0.653
AC:
1375
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1785
3570
5355
7140
8925
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.609
Hom.:
44415
Bravo
AF:
0.648
Asia WGS
AF:
0.721
AC:
2506
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 27, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, childhood absence, susceptibility to, 6 Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 28, 2017
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.2
DANN
Benign
0.42
PhyloP100
-2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2738893; hg19: chr16-1269029; COSMIC: COSV52358441; COSMIC: COSV52358441; API